Synthetic human livers for modeling metabolic diseases

Area of Science:

• Biotechnology
• Regenerative Medicine
• Synthetic Biology

Background:

• Human induced pluripotent stem cells (iPSCs) offer a powerful platform for studying metabolic liver diseases.
• Advances in biofabrication and gene editing are enabling the creation of more complex and accurate liver tissue models.

Purpose of the Study:

• To review recent progress in iPSC-based modeling of metabolic liver disease.
• To explore the biofabrication of synthetic human liver tissue.
• To discuss the application of synthetic biology in creating physiologically relevant liver disease models.

Main Methods:

• Utilizing human induced pluripotent stem cells (iPSCs) for disease modeling.
• Employing biofabrication techniques for synthetic liver tissue generation.
• Applying synthetic biology tools, including gene editing, to engineer liver models.

Main Results:

• iPSC-based liver tissue models recapitulate complex liver architecture and cell interactions.
• These models effectively replicate liver disease pathways.
• Synthetic biology approaches enhance the control and relevance of engineered liver models.

Conclusions:

• iPSC-based liver tissue is becoming a key tool for disease modeling and basic research.
• Further developments will significantly impact personalized medicine and autologous transplantation.
• The integration of synthetic biology promises more accurate and functional liver disease models.